Aldeyra Therapeutics Statistics Share Statistics Aldeyra Therapeutics has 60.05M
shares outstanding. The number of shares has increased by 0.8%
in one year.
Shares Outstanding 60.05M Shares Change (YoY) 0.8% Shares Change (QoQ) 0.31% Owned by Institutions (%) 63.26% Shares Floating 58.17M Failed to Deliver (FTD) Shares 1,809 FTD / Avg. Volume 0.18%
Short Selling Information The latest short interest is 5.38M, so 8.98% of the outstanding
shares have been sold short.
Short Interest 5.38M Short % of Shares Out 8.98% Short % of Float 9.26% Short Ratio (days to cover) 6.1
Valuation Ratios The PE ratio is -5.31 and the forward
PE ratio is 33.
Aldeyra Therapeutics's PEG ratio is
-0.11.
PE Ratio -5.31 Forward PE 33 PS Ratio 0 Forward PS 3.9 PB Ratio 4.18 P/FCF Ratio -6.87 PEG Ratio -0.11
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aldeyra Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.59,
with a Debt / Equity ratio of 0.22.
Current Ratio 5.59 Quick Ratio 5.59 Debt / Equity 0.22 Debt / EBITDA -0.29 Debt / FCF -0.35 Interest Coverage -31.21
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-6.21M Employee Count 9 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -7.82% in the
last 52 weeks. The beta is 0.79, so Aldeyra Therapeutics's
price volatility has been higher than the market average.
Beta 0.79 52-Week Price Change -7.82% 50-Day Moving Average 5.37 200-Day Moving Average 4.59 Relative Strength Index (RSI) 43.93 Average Volume (20 Days) 1,012,315
Income Statement
Revenue n/a Gross Profit -249.62K Operating Income -60.12M Net Income -55.85M EBITDA -53.68M EBIT -53.93M Earnings Per Share (EPS) -0.94
Full Income Statement Balance Sheet The company has 54.53M in cash and 15.3M in
debt, giving a net cash position of 39.22M.
Cash & Cash Equivalents 54.53M Total Debt 15.3M Net Cash 39.22M Retained Earnings -450.11M Total Assets 84.96M Working Capital 55.03M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -43.21M
and capital expenditures 0, giving a free cash flow of -43.21M.
Operating Cash Flow -43.21M Capital Expenditures n/a Free Cash Flow -43.21M FCF Per Share -0.73
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
